Latest News

New guidance on neurological complications of long COVID


 

FROM PHYSICIAN MEDICINE & REHABILITATION

The American Academy of Physical Medicine and Rehabilitation (AAPM&R) has issued new consensus guidance on the assessment and treatment of neurologic sequelae in patients with long COVID, also known as postacute sequelae of SARS-CoV-2 infection (PASC).

The new recommendations, which were published online in Physical Medicine & Rehabilitation, are the result of a collaboration between experts from a variety of medical specialties at 41 long COVID clinics across the United States.

Because physical medicine specialists treat individuals with disability and functional impairments, the AAPM&R was among the first organizations to initiate guidance for the assessment and treatment of long COVID and issued its first consensus statement that addressed long COVID–related fatigue in 2021.

Even though the number of COVID cases and hospitalizations has declined from the peak, long COVID continues to be a major public health issue, Steven R. Flanagan, MD, AAPM&R president-elect and Howard A. Rusk Professor of Rehabilitation Medicine at NYU Langone Health, New York, told reporters attending a press briefing.

“There is some evidence that some of the antivirals may actually help reduce the incidence but not everybody gets them,” said Dr. Flanagan. “In our own clinic here, we continue to see many, many people with problems associated with long COVID,” he added.

According to the consensus guidelines, about 80% of patients hospitalized with acute COVID-19 have neurological symptoms. But these symptoms are not just limited to people who had severe illness, said Leslie Rydberg, MD, coauthor of the neurology long COVID guidance statement.

“What we know is that many people with mild or moderate COVID infection end up with neurologic sequelae that last longer than 4 weeks,” said Dr. Rydberg, the Henry and Monika Betts Medical Student Education Chair and assistant residency program director at Shirley Ryan AbilityLab, Chicago.

Dr. Rydberg added that patients who have symptoms for longer than a month after the initial infection should be evaluated. Although the definition of what constitutes PASC is evolving, the guidance states that the literature indicates that it should be defined as the persistence of symptoms 4 weeks beyond the initial infection.

The most common neurological symptoms are headache, weakness, muscular pain, nerve pain, tremors, peripheral nerve issues, sleep issues, and cognitive effects, Dr. Rydberg told reporters.

She added that “identifying patients with progressive or ominous ‘red flag’ neurological symptoms is essential for emergent triaging.”

Among the red flags are sudden or progressive weakness or sudden or progressive sensory changes, because those could indicate an acute neurologic condition – either due to long COVID or other illnesses – such as a stroke or a problem with the spinal cord, Guillain-Barré syndrome, or myopathy.

While those signs and symptoms would likely be flagged by most clinicians, some of the emergent or urgent signs – such as upper motor neuron changes on physical exam – are more subtle, said Dr. Rydberg.

The new guidance spells out steps for initial evaluation, including identification of red flag symptoms, and also provides treatment recommendations.

Experts also recommend clinicians do the following:

  • Treat underlying medical conditions such as pain, psychiatric, cardiovascular, respiratory, and other conditions that may be contributing to neurologic symptoms.
  • Consider polypharmacy reduction, looking especially closely at medications with a known impact on neurologic symptoms.
  • Urge patients to get regular physical activity, as tolerated, while avoiding overuse syndrome.
  • Work with physical, occupational, and speech therapists to increase function and independence.
  • Refer patients to counseling and community resources for risk factor modification.

Pages

Recommended Reading

Doctor’s checklist for treating long COVID patients
MDedge Internal Medicine
Long COVID hitting some states, minorities, women harder
MDedge Internal Medicine
Long COVID: ‘On par’ with heart disease, cancer, book says
MDedge Internal Medicine
Trial shows some relief for long COVID fatigue, researchers say
MDedge Internal Medicine
Long COVID mobile monitoring study hunts for answers
MDedge Internal Medicine
Long-COVID patients respond differently to COVID vaccines
MDedge Internal Medicine
Researchers seek to understand post-COVID autoimmune disease risk
MDedge Internal Medicine
Long-COVID rate may be higher with rheumatic diseases
MDedge Internal Medicine
Clinical trials: Top priority for long COVID
MDedge Internal Medicine
Could vitamin D supplementation help in long COVID?
MDedge Internal Medicine